GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Yew Bio-Pharm Group Inc (OTCPK:YEWB) » Definitions » Price-to-Tangible-Book

Yew Bio-Pharm Group (Yew Bio-Pharm Group) Price-to-Tangible-Book : 0.01 (As of Apr. 26, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Yew Bio-Pharm Group Price-to-Tangible-Book?

As of today (2024-04-26), Yew Bio-Pharm Group's share price is $0.0002. Yew Bio-Pharm Group's Tangible Book per Share of Sep. 2021 for the quarter that ended in Sep. 2021 was $0.02. Hence, Yew Bio-Pharm Group's Price to Tangible Book Ratio of today is 0.01.

The historical rank and industry rank for Yew Bio-Pharm Group's Price-to-Tangible-Book or its related term are showing as below:

YEWB's Price-to-Tangible-Book is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 1.68
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Yew Bio-Pharm Group's share price is $0.0002. Yew Bio-Pharm Group's Book Value per Sharefor the quarter that ended in Sep. 2021 was $0.91. Hence, Yew Bio-Pharm Group's P/B Ratio of today is 0.00.


Yew Bio-Pharm Group Price-to-Tangible-Book Historical Data

The historical data trend for Yew Bio-Pharm Group's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yew Bio-Pharm Group Price-to-Tangible-Book Chart

Yew Bio-Pharm Group Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 0.27 2.03 3.20 1.62

Yew Bio-Pharm Group Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.80 1.62 0.90 1.31 6.90

Competitive Comparison of Yew Bio-Pharm Group's Price-to-Tangible-Book

For the Farm Products subindustry, Yew Bio-Pharm Group's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yew Bio-Pharm Group's Price-to-Tangible-Book Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Yew Bio-Pharm Group's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Yew Bio-Pharm Group's Price-to-Tangible-Book falls into.



Yew Bio-Pharm Group Price-to-Tangible-Book Calculation

Yew Bio-Pharm Group's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2021 )
=0.0002/0.021
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Yew Bio-Pharm Group Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Yew Bio-Pharm Group's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Yew Bio-Pharm Group (Yew Bio-Pharm Group) Business Description

Traded in Other Exchanges
N/A
Address
9460 Telstar Avenue, Suite 6, El Monte, CA, USA, 91731
Yew Bio-Pharm Group Inc is a grower and seller of yew trees and manufacturer of products made from yew trees in China. The company also sells raw material, including the branches and leaves of yew trees, used in the manufacturing of traditional Chinese medicines, which are used as a secondary treatment for certain cancers, meaning they must be administered in combination with other pharmaceutical drugs. The company operating business segments are China and the United States, of which the majority of its revenue comes from China.
Executives
Yongchun Shi director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91302
Xiefeng Liu director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Guoshuang Tian director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Xuehai Wu director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Xingming Han director DOOR 3, FLOOR 7, VIC NO.23 TONGZHAN ST. XIANGFANG DISTRICT HARBIN CITY F4 XXXXXXXXX
Adam C Wasserman officer: Chief Financial Officer 1643 ROYAL GROVE WAY, WESTON FL 33327
Guifang Qi director, officer: Treasurer 501 N. MOORE AVE. APT. A MONTEREY PARK CA 91754
Zhiguo Wang director, officer: President and Secretary NO. 234, GEXIN STREET NANGANG DISTRICT HARBIN CITY F4 XXXXXXXXX

Yew Bio-Pharm Group (Yew Bio-Pharm Group) Headlines

From GuruFocus

Yew Bio-Pharm Group Announces New Significant Agreement

By Marketwired Marketwired 09-12-2018

Yew Bio-Pharm Group Announces New Cosmetic Subsidiary

By Marketwired Marketwired 03-09-2021